Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Characterization of Omicron XBB subvariants in Vietnam

Breadcrumb

  • Home
  • Characterization of Omicron XBB Subvariants In Vietnam
  • Characterization of Omicron XBB subvariants in Vietnam

Quan Ke Thai 1, * and Phuoc Huynh 2

1 Saigon University, 273 An Duong Vuong, Ward 3 District 5, Ho Chi Minh city, Vietnam, 700000. ORCID: 0000-0002-2264-2579
2 VNU HCMC University of Science, 227 Nguyen Van Cu, Ward 4 District 5, Ho Chi Minh city, Vietnam, 700000. ORCID: 0000-0003-3066-4580.
 
Research Article
GSC Biological and Pharmaceutical Sciences, 2023, 24(03), 337–343.
Article DOI: 10.30574/gscbps.2023.24.3.0400
DOI url: https://doi.org/10.30574/gscbps.2023.24.3.0400
Received on 16 August 2023; revised on 27 September 2023; accepted on 29 September 2023
 
SARS-CoV-2, an RNA virus that causes COVID-19, is known for its high mutation rate. Its latest variant, Omicron, has raised concerns due to several amino acid substitutions in the spike protein that could increase its transmissibility and virulence. Omicron has also produced subvariants with specific nucleotide mutations to evade antibodies and enhance infectivity. One of these subvariants, XBB, has become prevalent in Vietnam. Therefore, it is essential to accurately assess the genetic diversity of this emerging variant. This study analyzed the April 15th, 2023 updated data and identified nine XBB and subvariants in Vietnam, with XBB.1.5 being the most common. Phylogenetic analysis revealed that the original XBB variant was related to BA.2.75, and XBB.1.5 had a close relationship with XBB.1.2. A crucial mutation, G22317T (G252V), played an essential role in the emergence of the XBB subvariant, and XBB.1.5 split from XBB.1.2 with an A22405T (E281D) mutation, as shown by the mutation network.
Spike gene; SARS-CoV-2; Genetic diversity; Omicron; Vietnam; XBB
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2023-…

Preview Article PDF

Quan Ke Thai and Phuoc Huynh. Characterization of Omicron XBB subvariants in Vietnam. GSC Biological and Pharmaceutical Sciences, 2023, 24(3), 337-343. Article DOI: https://doi.org/10.30574/gscbps.2023.24.3.0400


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution